Share this page:
Other services (opens in new window)
Sets a cookie

Industry welcomes funding for the ELIXIR research infrastructure

5 December 2011

Earlier today the Department for Business, Innovation and Skills announced a £75M commitment from the Large Facilities Capital Fund (LFCF) for the ELIXIR research infrastructure.

BBSRC and The European Molecular Biology Laboratory's European Bioinformatics Institute were joined in welcoming the news by industry representatives:

Glyn Edwards, interim Chief Executive of the BioIndustry Association (BIA) said "The BIA welcomes the government's decision to invest in the ELIXIR programme at the European Bioinformatics Institute near Cambridge. ELIXIR will provide UK bioscience companies with a valuable resource to support bioscience research and its translation and help drive the future knowledge-based bio-economy."

Louise Leong, Head of Research and Development at the Association of the British Pharmaceutical Industry, commented "The rapid advent of new science and technologies means that pharmaceutical research and development is increasingly complex, multi-disciplinary and interdependent. R&D therefore relies on effective coordination and curation of life science data. Without good access to such data, time and resources are wasted duplicating effort, which could be spent creating innovative new medicines. ELIXIR will ensure that public data resources are sufficiently diverse and forward-looking enough to remain relevant to business needs."

Dr. Friedrich Rippmann, Director of Computational Chemistry at Merck Serono, said "As a research-based chemical and pharmaceutical company we rely heavily on data and research provided by the European Bioinformatics Institute. We are convinced about the value that bioinformatics infrastructure operated by EBI provides, both to us as a company and to the UK and Europe as a whole.

"By developing research infrastructure in Cambridge the UK has kick started its genome capabilities on a world competitive scale."

Simon Thornber of GlaxoSmithKline said "The announcement of new funding for the ELIXIR project is very welcome, & will help provide the state of the art high performance computing infrastructure needed to underpin the next decade of pan-European life sciences research at the EBI."

ENDS

Contact

BBSRC Media Office

tel: 01793 414694